GLGC Gene Logic Inc. (MM)

Gene Logic Inc. (NASDAQ:GLGC) announced today it has signed an agreement with GE Healthcare for global distribution of Gene Logic's new SCIANTIS(TM) System, an online gene expression analysis system developed for use by academic, government and other non-profit research organizations. GE Healthcare will distribute the system in 32 countries and will be the exclusive distributor in Japan. Financial details of the agreement were not disclosed. The SCIANTIS System is user friendly, browser based, and designed to help researchers quickly and easily profile the expression of human, rat and mouse genes in normal and diseased tissues in order to better understand the relationship of gene expression to biological function and mechanisms of disease. The system is based on Gene Logic's gene expression reference database, which allows accurate expression comparisons due to the Company's industry-leading quality control metrics and sample processing automation, which are employed at its state-of-the-art facility. The SCIANTIS System features: -- Gene expression profiles from more than 6,000 human, rat, and mouse tissue samples curated by expert pathologists into more than 800 sample sets. -- Summary expression data for more than 30,000 genes in each sample set. -- Proprietary software that allows researchers to quickly visualize data of interest and generate reports regarding gene expression across a wide variety of cell lines or tissues. -- Data segmented into five disease areas, including inflammation, cardiovascular disease, oncology, central nervous system disorders, and metabolic diseases. Dennis Rossi, senior vice president and general manager, Genomics for Gene Logic, said, "We designed the SCIANTIS System for the thousands of academic and university researchers who have not had access to the same gene expression analysis systems as their industry counterparts. We have coupled this new product with GE Healthcare's strong brand and powerful worldwide marketing and sales capabilities. We are positioned to significantly broaden our customer base in alliance with one of the largest and best-known corporations in the world, through GE Healthcare's innovative marketing, web commerce, direct selling and broad distributor network." Ger Brophy, head of product acquisition and licensing, GE Healthcare said, "We are excited to work with Gene Logic, a leader in genomics services, to distribute the SCIANTIS System, an innovative and effective way for researchers to more efficiently analyze genetic expression data. The SCIANTIS System is a valuable addition to the technologies and services GE Healthcare offers to our life sciences customers." Gene Logic Overview Gene Logic aspires to be the most valued drug development solutions partner to the pharmaceutical industry. Gene Logic applies its broad and unique mix of technologies, talent and methodologies to work on behalf of its partners to enable pharmaceutical and biotechnology companies to make more informed, more reliable and more predictive decisions at each point in the highly complex and costly drug development process. For more information, visit www.genelogic.com or call toll-free - 1/800/GENELOGIC. About GE Healthcare GE Healthcare provides transformational medical technologies that will shape a new age of patient care. GE Healthcare's expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, disease research, drug discovery and biopharmaceutical manufacturing technologies is dedicated to detecting disease earlier and helping physicians tailor treatment for individual patients. GE Healthcare offers a broad range of services to improve productivity in healthcare and enable healthcare providers to better diagnose, treat and manage patients with conditions such as cancer, neurological and cardiovascular diseases. GE Healthcare is a $14 billion unit of General Electric Company (NYSE: GE) that is headquartered in the United Kingdom. Worldwide, GE Healthcare employs more than 42,500 people committed to serving healthcare professionals and their patients in more than 100 countries. For more information about GE Healthcare, visit our website at: www.gehealthcare.com.